BSEBoard Meeting21 Oct 2026 · 21 Oct 2026, 08:34 pm
Vineet Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/10/2026 ,inter alia, to consider and approve the unaudited Standalone Financial Results of the Company for the first quarter ended on June 30, 2026 along with the Limited Review Report
Vineet Laboratories Ltd · 543298
✦ AI SummaryResults
Vineet Laboratories Ltd has scheduled a Board Meeting on 26/10/2026 to consider and approve the unaudited standalone financial results for the first quarter ended 30/06/2026 along with the Limited Review Report.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Vineet Laboratories Ltd - 543298 - Board Meeting Intimation for 1. Approval Of Un Audited Financial Results For The Quarter Ended 30.06.2026
2. Any Other Business
Attachments (1)
📄pdf
Download →
35ecf7d1-c628-4b31-be33-260384ebe889.pdf
View document text
October 21st, 2026
To To
BSE Limited, National Stock Exchange of India Limited,
Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1, Block G,
Dalal Street, Bandra Kurla Complex,
Mumbai- 400 001. Bandra (E),
Mumbai – 400 051.
BSE Scrip Code: 543298 NSE Scrip Code: VINEETLAB
Dear Sir / Ma’am,
Sub: Intimation of the date of Board Meeting under Regulation 29 of SEBI (Listing Obligations and
Disclosure Requirements) Regulations, 2015.
This is to inform you that a meeting of Board of Directors of the Company is scheduled to be held on Monday,
26th October 2026.
The purpose of the Board Meeting is -
To consider and approve the unaudited standalone financial results of the Company for the first quarter
ended on June 30, 2026 along with the Limited Review Report.
"In accordance with the provisions of the SEBI (Prohibition of Insider Trading) Regulations, 2015, read with the
Company's Code of Conduct to Regulate, Monitor and Report Trading by Insiders, the Trading Window for
dealing in the equity shares of the Company remained closed for all Designated Persons, their immediate
relatives, and other connected persons covered under the said Code until 48 hours after the declaration of the
financial results for the quarter ended 30th September 2026."
This is for your records.
Thanking you,
Best Regards,
For Vineet Laboratories Limited
RAJESH KUMAR KATHULLA
Director
DIN: 05349717